New York State Psychiatric Institute: Bipolar Disorder trials

The registry lists 19 Bipolar Disorder studies with New York State Psychiatric Institute as lead sponsor. 1 are open to participants now and 13 have results posted.

Phase 1 3Phase 2 2Phase 3 1Phase 4 10No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Exercise and Olanzapine-samidorphanRecruitingNCT06740890Phase 4
• A Trial of "Opening Doors to Recovery" for Persons With Serious Mental IllnessesCompletedNCT04612777Not applicableResults posted
• Treating Self Injurious Behavior: A Novel Brain Stimulation ApproachCompletedNCT04244786Not applicableResults posted
• 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar DisorderCompletedNCT03902613Phase 4Results posted
• Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET ImagingCompletedNCT02473250Phase 4Results posted
• Biosignatures of Latuda for Bipolar DepressionCompletedNCT02239094Not applicableResults posted
• Ketamine for Suicidality in Bipolar DepressionCompletedNCT01944293Phase 1/2Results posted
• Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older AdultsCompletedNCT01869374Phase 1/2Results posted
• NMDA Antagonists in Bipolar DepressionCompletedNCT01833897Phase 4Results posted
• Wake Therapy in the Treatment of DepressionCompletedNCT01431573Not applicableResults posted
• Tranylcypromine Treatment of Bipolar DepressionCompletedNCT01430455Phase 4Results posted
• A Pilot Study Assessing EmSam in Bipolar DepressionTerminatedNCT00535262Phase 4Results posted
• Open-label Ziprasidone Study for Psychosis Treatment in AdolescentsCompletedNCT00421954Phase 3Results posted
• Early Detection and Prevention of Mood Disorders in Children of Parents With Bipolar DisorderCompletedNCT00338806Not applicableResults posted
• Dopamine D3 Receptor Occupancy in Bipolar DepressionWithdrawnNCT05060549Phase 4
• A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic AcidWithdrawnNCT04811404Phase 4
• IM Ketamine vs Midazolam for Suicidal ER PatientsSuspendedNCT04640636Phase 4
• Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar DisorderCompletedNCT00563992Phase 1
• Optimizing Electroconvulsive Therapy for DepressionCompletedNCT00045916Phase 4